Monoacylated Cellular Prion Proteins Reduce Amyloid-β-Induced Activation of Cytoplasmic Phospholipase A2 and Synapse Damage

Alzheimer’s disease (AD) is a progressive neurodegenerative disease characterized by the accumulation of amyloid-β (Aβ) and the loss of synapses. Aggregation of the cellular prion protein (PrPC) by Aβ oligomers induced synapse damage in cultured neurons. PrPC is attached to membranes via a glycosylp...

Full description

Bibliographic Details
Main Authors: Ewan West, Craig Osborne, William Nolan, Clive Bate
Format: Article
Language:English
Published: MDPI AG 2015-06-01
Series:Biology
Subjects:
Online Access:http://www.mdpi.com/2079-7737/4/2/367
_version_ 1797712239123234816
author Ewan West
Craig Osborne
William Nolan
Clive Bate
author_facet Ewan West
Craig Osborne
William Nolan
Clive Bate
author_sort Ewan West
collection DOAJ
description Alzheimer’s disease (AD) is a progressive neurodegenerative disease characterized by the accumulation of amyloid-β (Aβ) and the loss of synapses. Aggregation of the cellular prion protein (PrPC) by Aβ oligomers induced synapse damage in cultured neurons. PrPC is attached to membranes via a glycosylphosphatidylinositol (GPI) anchor, the composition of which affects protein targeting and cell signaling. Monoacylated PrPC incorporated into neurons bound “natural Aβ”, sequestering Aβ outside lipid rafts and preventing its accumulation at synapses. The presence of monoacylated PrPC reduced the Aβ-induced activation of cytoplasmic phospholipase A2 (cPLA2) and Aβ-induced synapse damage. This protective effect was stimulus specific, as treated neurons remained sensitive to α-synuclein, a protein associated with synapse damage in Parkinson’s disease. In synaptosomes, the aggregation of PrPC by Aβ oligomers triggered the formation of a signaling complex containing the cPLA2.a process, disrupted by monoacylated PrPC. We propose that monoacylated PrPC acts as a molecular sponge, binding Aβ oligomers at the neuronal perikarya without activating cPLA2 or triggering synapse damage.
first_indexed 2024-03-12T07:18:45Z
format Article
id doaj.art-03caae40076643709e25dcbd097ddfec
institution Directory Open Access Journal
issn 2079-7737
language English
last_indexed 2024-03-12T07:18:45Z
publishDate 2015-06-01
publisher MDPI AG
record_format Article
series Biology
spelling doaj.art-03caae40076643709e25dcbd097ddfec2023-09-02T22:36:58ZengMDPI AGBiology2079-77372015-06-014236738210.3390/biology4020367biology4020367Monoacylated Cellular Prion Proteins Reduce Amyloid-β-Induced Activation of Cytoplasmic Phospholipase A2 and Synapse DamageEwan West0Craig Osborne1William Nolan2Clive Bate3Department of Pathology and Pathogen Biology, Royal Veterinary College, Hawkshead Lane, North Mymms, Herts AL97TA, UKDepartment of Pathology and Pathogen Biology, Royal Veterinary College, Hawkshead Lane, North Mymms, Herts AL97TA, UKDepartment of Pathology and Pathogen Biology, Royal Veterinary College, Hawkshead Lane, North Mymms, Herts AL97TA, UKDepartment of Pathology and Pathogen Biology, Royal Veterinary College, Hawkshead Lane, North Mymms, Herts AL97TA, UKAlzheimer’s disease (AD) is a progressive neurodegenerative disease characterized by the accumulation of amyloid-β (Aβ) and the loss of synapses. Aggregation of the cellular prion protein (PrPC) by Aβ oligomers induced synapse damage in cultured neurons. PrPC is attached to membranes via a glycosylphosphatidylinositol (GPI) anchor, the composition of which affects protein targeting and cell signaling. Monoacylated PrPC incorporated into neurons bound “natural Aβ”, sequestering Aβ outside lipid rafts and preventing its accumulation at synapses. The presence of monoacylated PrPC reduced the Aβ-induced activation of cytoplasmic phospholipase A2 (cPLA2) and Aβ-induced synapse damage. This protective effect was stimulus specific, as treated neurons remained sensitive to α-synuclein, a protein associated with synapse damage in Parkinson’s disease. In synaptosomes, the aggregation of PrPC by Aβ oligomers triggered the formation of a signaling complex containing the cPLA2.a process, disrupted by monoacylated PrPC. We propose that monoacylated PrPC acts as a molecular sponge, binding Aβ oligomers at the neuronal perikarya without activating cPLA2 or triggering synapse damage.http://www.mdpi.com/2079-7737/4/2/367Alzheimer’s diseaseamyloid-βglycosylphosphatidylinositolsprionsynapsessynaptophysin
spellingShingle Ewan West
Craig Osborne
William Nolan
Clive Bate
Monoacylated Cellular Prion Proteins Reduce Amyloid-β-Induced Activation of Cytoplasmic Phospholipase A2 and Synapse Damage
Biology
Alzheimer’s disease
amyloid-β
glycosylphosphatidylinositols
prion
synapses
synaptophysin
title Monoacylated Cellular Prion Proteins Reduce Amyloid-β-Induced Activation of Cytoplasmic Phospholipase A2 and Synapse Damage
title_full Monoacylated Cellular Prion Proteins Reduce Amyloid-β-Induced Activation of Cytoplasmic Phospholipase A2 and Synapse Damage
title_fullStr Monoacylated Cellular Prion Proteins Reduce Amyloid-β-Induced Activation of Cytoplasmic Phospholipase A2 and Synapse Damage
title_full_unstemmed Monoacylated Cellular Prion Proteins Reduce Amyloid-β-Induced Activation of Cytoplasmic Phospholipase A2 and Synapse Damage
title_short Monoacylated Cellular Prion Proteins Reduce Amyloid-β-Induced Activation of Cytoplasmic Phospholipase A2 and Synapse Damage
title_sort monoacylated cellular prion proteins reduce amyloid β induced activation of cytoplasmic phospholipase a2 and synapse damage
topic Alzheimer’s disease
amyloid-β
glycosylphosphatidylinositols
prion
synapses
synaptophysin
url http://www.mdpi.com/2079-7737/4/2/367
work_keys_str_mv AT ewanwest monoacylatedcellularprionproteinsreduceamyloidbinducedactivationofcytoplasmicphospholipasea2andsynapsedamage
AT craigosborne monoacylatedcellularprionproteinsreduceamyloidbinducedactivationofcytoplasmicphospholipasea2andsynapsedamage
AT williamnolan monoacylatedcellularprionproteinsreduceamyloidbinducedactivationofcytoplasmicphospholipasea2andsynapsedamage
AT clivebate monoacylatedcellularprionproteinsreduceamyloidbinducedactivationofcytoplasmicphospholipasea2andsynapsedamage